| Literature DB >> 34731053 |
Philip Dershwitz1, Wenyu Gu2, Julien Roche1, Christina S Kang-Yun2, Jeremy D Semrau2, Thomas A Bobik1, Bruce Fulton1, Hans Zischka3,4, Alan A DiSpirito1.
Abstract
Methanobactins (MBs) are ribosomally synthesized and posttranslationally modified peptides (RiPPs) produced by methanotrophs for copper uptake. The posttranslational modification that defines MBs is the formation of two heterocyclic groups with associated thioamines from X-Cys dipeptide sequences. Both heterocyclic groups in the MB from Methylosinus trichosporium OB3b (MB-OB3b) are oxazolone groups. The precursor gene for MB-OB3b is mbnA, which is part of a gene cluster that contains both annotated and unannotated genes. One of those unannotated genes, mbnC, is found in all MB operons and, in conjunction with mbnB, is reported to be involved in the formation of both heterocyclic groups in all MBs. To determine the function of mbnC, a deletion mutation was constructed in M. trichosporium OB3b, and the MB produced from the ΔmbnC mutant was purified and structurally characterized by UV-visible absorption spectroscopy, mass spectrometry, and solution nuclear magnetic resonance (NMR) spectroscopy. MB-OB3b from the ΔmbnC mutant was missing the C-terminal Met and was also found to contain a Pro and a Cys in place of the pyrrolidinyl-oxazolone-thioamide group. These results demonstrate MbnC is required for the formation of the C-terminal pyrrolidinyl-oxazolone-thioamide group from the Pro-Cys dipeptide, but not for the formation of the N-terminal 3-methylbutanol-oxazolone-thioamide group from the N-terminal dipeptide Leu-Cys. IMPORTANCE A number of environmental and medical applications have been proposed for MBs, including bioremediation of toxic metals and nanoparticle formation, as well as the treatment of copper- and iron-related diseases. However, before MBs can be modified and optimized for any specific application, the biosynthetic pathway for MB production must be defined. The discovery that mbnC is involved in the formation of the C-terminal oxazolone group with associated thioamide but not for the formation of the N-terminal oxazolone group with associated thioamide in M. trichosporium OB3b suggests the enzymes responsible for posttranslational modification(s) of the two oxazolone groups are not identical.Entities:
Keywords: aerobic methane oxidation; chalkophore; methanobactin; methanotroph; ribosomally synthesized and posttranslational modified peptide
Mesh:
Substances:
Year: 2021 PMID: 34731053 PMCID: PMC8788703 DOI: 10.1128/AEM.01841-21
Source DB: PubMed Journal: Appl Environ Microbiol ISSN: 0099-2240 Impact factor: 4.792
Strains, plasmids, and primers used in this study
| Strain, plasmid, or primer | Description | Restriction site | Reference or source |
|---|---|---|---|
| Strains | |||
|
| |||
| TOP10 | F−
| Invitrogen | |
| S17-1 |
| ||
|
| |||
| OB3b | Wild-type strain | ||
| Δ |
| ||
| Δ | Δ | this study | |
| Plasmids | |||
| pTJS140 | Broad-host-range cloning vector; Mob Apr Spr Smr
|
| |
| pWG104 | pTJS140 carrying | This study | |
| Primers | |||
| mbnANf |
| KpnI |
|
| mbnANr |
| KpnI |
|
| mbn66 |
| BamHI | This study |
| mbn70 |
| BamHI | This study |
| qmbnA_FO |
|
| |
| qmbnA_RO |
|
| |
| qmbnB_F1 |
| This study | |
| qmbnB_R2 |
| This study | |
| dmbnC_F |
| This study | |
| dmbnC_R |
| This study | |
| qmbnM_F |
| This study | |
| qmbnM_R |
| This study | |
| qmbnN_F |
| This study | |
| qmbnN_R |
| This study | |
| qmbnP_F |
| This study | |
| qmbnP_R |
| This study | |
| qmbnH_F |
| This study | |
| qmbnH_R |
| This study | |
Added overhangs for binding by restriction enzyme are underlined. Restriction sites are noted with lowercase letters.
FIG 1UV-visible absorption spectra of MB-OB3b (blue) and the ΔmbnC mutant (red). Abbreviations: OxaA, oxazolone A or the N-terminal oxazolone group; OxaB, oxazolone B or the C-terminal oxazolone group.
FIG 2MALDI-TOF MS of methanobactin from ΔmbnC.
FIG 3(A) Structure of wild-type MB-OB3b, with the labile terminal methionine in gray. (B) Proposed structure of the ΔmbnC mutant based on UV-visible absorption spectra, LC-MS, and NMR analysis. The differences between MB-OB3b-Met and the ΔmbnC mutant are highlighted in red. (C) Amino acid sequence of (a) wild-type MB-OB3b minus the C-terminal Met and (b) the ΔmbnC mutant.
FIG 4The 800-MHz 1H-15N-HSQC spectrum of uniformly 15N-labeled ΔmbnC mutant in 90% 9 mM phosphate buffer (pH 6.5) and 10% D2O at 265 K and 300,000,000 Pa. The horizontal and vertical 1D spectra are 1H and 15N spectra, respectively.
1H, 13C, and 15N resonances for metal-free ΔmbnC mutant
| Residue | Atom | Chemical shift (ppm) | Residue | Atom | Chemical shift (ppm) | ||||
|---|---|---|---|---|---|---|---|---|---|
| 1H | 13C | 15N | 1H | 13C | 15N | ||||
| 3-Methyl-butanoyl | C1 | 174.6 | Tyr4 | HN | 7.44 | ||||
| C2 | 50.5 | Hα | 2.96 | ||||||
| C3 | 38.0 | Hβ | 2.79 | ||||||
| C4 | 19.6 | Hβ | 1.20 | ||||||
| C5 | 19.6 | H2,6 | 6.11 | ||||||
| H2 | 4.15 | H3,5 | 6.45 | ||||||
| H3 | 2.17 | Pro5 | N1 | 109.6 | |||||
| H3 | 2.72 | C2 | 67.3 | ||||||
| H4 | 1.88 | C3 | 21.1 | ||||||
| H5 | 1.80 | C4 | 39.5 | ||||||
| Oxazolone | N | 180.1 | C5 | 55.2 | |||||
| HN | 7.61 | H2 | 3.67 | ||||||
| Gly1 | N | 125.1 | H3 | 1.06 | |||||
| C | H3 | 2.13 | |||||||
| Cα | 26.6 | H4 | 1.28 | ||||||
| HN | 9.57 | H4 | 2.29 | ||||||
| Hα | 1.46 | H5 | 2.79 | ||||||
| Ser2 | N | 114.3 | H5 | 2.96 | |||||
| C | 181.6 | Cys6 | N | 127.9 | |||||
| Cα | 72 | C | 136.3 | ||||||
| Cβ | Cα | 53.3 | |||||||
| HN | 8.19 | Cβ | 49.3 | ||||||
| Hα | 4.14 | HN | 8.43 | ||||||
| Hβ | 3.98 | Hα | 3.96 | ||||||
| Hβ | 1.41 | Hβ | 3.23 | ||||||
| Cys3 | N | 118.1 | Hβ | 1.38 | |||||
| C | 173.0 | Ser7 | N | 117.5 | |||||
| Cα | 71.2 | C | |||||||
| Cβ | 35.6 | Cα | 51.6 | ||||||
| HN | 7.93 | Cβ | 45.0 | ||||||
| Hα | 3.96 | HN | 8.90 | ||||||
| Hβ | 3.23 | Hα | 4.19 | ||||||
| Hβ | 1.37 | Hβ | 3.25 | ||||||
| Tyr4 | N | 121.5 | Hβ | 1.48 | |||||
| C | Cys8 | N | 112.4 | ||||||
| Cα | 48.9 | C | 172.6 | ||||||
| Cβ | 35.6 | Cα | 42.3 | ||||||
| C1 | Cβ | 21.1 | |||||||
| C2,6 | HN | 8.47 | |||||||
| C3,5 | 135.4 | Hα | 3.69 | ||||||
| C4 | Hβ | 3.55 | |||||||
| Hβ | 0.97 | ||||||||
The table is presented in a two-column format (i.e., the table’s two “Residue” columns and corresponding data are independent from one another).
FIG 5(Top) MB-OB3b gene cluster. Genes with known involvement in MB-OB3b synthesis and transport are shown in blue. (Bottom) Proposed genes involved in the biosynthesis of the oxazolone rings with associated thioamides from MbnA. Additional, yet to be identified genes may also be involved in the formation of oxazolone groups.